Clinical Trial

Tiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced Non-squamous NSCLC

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated January 26, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
To evaluate the efficacy of tiragolumab with atezolizumab and bevacizumab in previously-treated advanced non-squamous NSCLC.
Protocol Amendment History 11 amendments
This ClinicalTrials.gov record has been amended 11 times since 2021-07-01; most recent amendment 2026-01-23.
Status change: Recruiting → Active, Not Recruiting 2025-10-15
Status change: Not Yet Recruiting → Recruiting 2021-12-02
Trial Details
NCT Number NCT04958811
Lead Sponsor Georgetown University
Collaborators: Genentech, Inc.
Conditions Non-squamous Non-small-cell Lung Cancer
Enrollment 29 participants
Start Date 2021-12-21
Primary Completion 2026-07 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-26